XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines … – The Herald | HeraldOnline.com

by admin on July 23, 2013

XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines
The Herald | HeraldOnline.com
The manuscript, published in the current issue of Sleep Medicine, provides information for physicians determining treatment choices for restless legs syndrome/Willis-Ekbom Disease (RLS/WED) based on the long-term benefits and risks of each major class

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: